Screener
Stryker SYK Knees — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Stryker in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Stryker’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 11:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000310764-26-000031
FAQ
- What is Stryker's knees — net sales?
- Stryker (SYK) reported knees — net sales of $670M in Q1 2026.
- How has Stryker's knees — net sales changed year-over-year?
- Stryker's knees — net sales increased by 4.9% year-over-year, from $639M to $670M.
- What is the long-term trend for Stryker's knees — net sales?
- Over 4 years (2021 to 2025), Stryker's knees — net sales has grown at a 9.5% compound annual growth rate (CAGR), from $1.85B to $2.66B.
- What does knees — net sales mean?
- This metric represents the total revenue generated from the sale of knee replacement implants, instrumentation, and related surgical products. It reflects the company's market performance within the reconstructive orthopedic segment, specifically targeting patients requiring total or partial knee arthroplasty. This revenue stream is a critical indicator of the company's competitive position in the elective surgery market and its ability to capture share in the global orthopedics industry.
Ask your AI about Stryker's knees — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude